Article
DM Clinical Research has opened its first research location in the Boston metropolitan area and Massachusetts. The company also announced it will soon start enrolling patients in Moderna's CMVictory Trial studying mRNA-1647, an investigational vaccine, to understand whether it can help the immune system protect against cytomegalovirus (CMV).
Read more about the new site and partnership here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.